NURS FPX 4025 Assessment 1 Diagnosis Benefit from Evidence-Based Practice

Student name

Capella University

NURS-FPX4025

Professor’s Name

Submission Date

Introduction

Acute myocardial infarction (AMI) is a severe emergency in the cardiovascular system and, consequently, entails a timely diagnosis of the disease and immediate administration of treatment to minimize the rate of death and enhance the prognosis of the victims. The AMI interventions, which are of quality oxygen therapy, nitroglycerin, aspirin, beta-blockers, and possibly angioplasty or stents. However, certain new details are also present, which start pointing at the fact that the intervention that is based on the original personalised profile of the patient may result in better outcomes.

Evidence-based practice (EBP) represents a relevant aspect of clinical decision-making that entails the management of AMI as it ensures nurses in question arrive at the most optimal possible decisions based on the existing knowledge (Alkhaqani, 2023). The given paper diagnoses acute myocardial infarction in collaboration with the assistance of an EBP model and locates the most suitable existing evidence to improve the given diagnosis and strategic treatment and reduce complications to the minimal, along with the highest possible survival rates. It is a systematic implementation of the research findings in order to make an addition of a higher view of the most sophisticated ways of managing AMI.                                                                      

The Role of Evidence-Based Practice in Treatment Selection

Among the main issues related to AMI, one can single out the question of the most suitable course of treatment, the choice between immediate treatment that can be angioplasty or thrombolysis, and the continuous medical treatment with pharmacological agents. The clinical factors that can affect this decision include the time of presentation by the patient, comorbid conditions, and the severity of coronary artery blockage. Conventional drugs such as aspirin, beta-blockers, and nitroglycerin have proved to be more effective when used early and adapted to the situation of the patient (Yin et al., 2024). Nevertheless, without an organized decision-making strategy, care delivery is not always conducted based on the existing best practices, which results in suboptimal outcomes. Also, non-pharmacological interventions, including lifestyle changes like smoking cessation, physical exercise, and nutritional changes, are also important in secondary prevention and better recovery, but are not consistently given the focus they deserve in acute care.

Implementing a treatment approach of AMI, based on EBP, can help overcome these complexities by involving current research evidence, clinical knowledge, and patient preference in the decision to provide care. EBP allows medical professionals to evaluate high-quality research in a systematic manner and convert it into feasible and personalized treatment plans. As an example, the protocols regarding the timing of invasive procedures when they are most useful can be informed by evidence collected using systematic reviews and clinical trials, and how timely pharmacologic and lifestyle interventions can be optimized. According to Himmelfarb et al. (2023), such an integrative approach will not only increase the efficacy of clinical interventions, but also patient safety and satisfaction, and the overall health outcomes of patients in the end. Therefore, the EBP application to the AMI management is an assurance that the care provided is scientifically based and patient-specific.

Application of the Evidence-Based Practice Model

Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) Model is a systematic method that may be used to assess and implement evidence in clinical decision-making, which would be most appropriate in the case of the treatment selection problem in AMI (Bolanos, 2023). One vital decision in the first step (Practice Question) might be that some of the profiles of patients are also well-advantaged to early invasive intervention like angioplasty rather than through only medical interventions. The second step (Evidence) searches and assesses the quality and relevance of the evidence to the AMI treatment in regards to significant literature and research, guidelines, and views of the specialists.

Lastly, Translation entails transferring the findings to clinical practice, carrying out recommendations, changes, and evaluation of findings (Steel et al., 2023). This model applies to the AMI treatment decision-making process since the decision-making process must rely on high-quality evidence and take into account the results of the patient, safety, and the possibility of treatment. Through this system approach, healthcare specialists can make sound judgments that will serve the best interest of the patient by affecting their treatment effectiveness and care.

Searching for Evidence Using the JHNEBP Model

The JHNEBP) The model was logically utilized to investigate the best treatment options for AMI. In terms of the Practice Question phase, it was obvious to state the clinical problem: In patients with AMI, are early invasive strategies (i.e., angioplasty) better than medical management of the patients? During the Evidence step, the search was conducted on the high-quality studies available in the medical databases with good reputability (i.e., recent clinical trials, systematic reviews, and clinical guidelines) (Jia et al., 2020). The difficulties were encountered in preventing the filtering of high-quality evidence out of the lower-level studies and in making sure that the chosen research applied to the AMI patients who had diverse risk factors and were at different disease stages. Also, care has been exercised to choose the evidence that is up-to-date and has a direct application to clinical practice.

During the Translation stage, the evidence was synthesized to determine whether the evidence was in favor of the change in clinical practice. This was a significant step towards addressing the difficulty in terms of weighing the potential good associated with early intervention, such as low mortality rates, against the risks of the process. This entailed utilizing the best available evidence in the framework of an evaluation of the evidence and transcending the potential obstacles to implementation, including resource limitations or patient-specific risks. Nonetheless, the JHNEBP model enabled a structured, evidence-based method to identify the best treatment plan to use in case of AMI, which enabled the incorporation of research results into clinical practice to enhance patient outcomes.

Challenges in Applying the JHNEBP Model

A number of challenges were experienced during the search process. One of the problems of the Evidence phase was the issue of separating high-quality studies and those with low applicability or outdated data. Moreover, it was a challenge to ensure that the gathered evidence was useful to the targeted population of patients with different stages and risk factors of AMI. The variation in the results of the studies made the Translation phase even more difficult since some of the studies advocated early invasive strategies, and some studies were concerned with the complications of the procedure. Although it has to be stated, the JHNEBP framework, nonetheless, provided a systematized way of navigating this dilemma with the intention of ensuring that the best evidence was deployed to guide clinical decisions and improve care of the victims of AMI (Damluji et al., 2021).

Credibility and Relevance of Evidence

The prevention interventions during the case of AMI would be determined by evaluation on the credibility and relevance of the available evidence, such as Journal of the American College of Cardiology, Circulation, and The Lancet, clinical guidelines, and systematic reviews. The best quality studies, like the Randomized Controlled Trials (RCTs) and meta analyses, are said to contain the most reliable data (Veettil et al., 2021). It is also necessary to choose recent studies and make them relevant to the definite population of patients, as they are relevant depending on their age, comorbid conditions, and the extent of the heart attack. Small studies, with small samples, old data, or those that have not examined outcomes that are critical (such as mortality, recurrence, or long-term recovery), could not be considered as the most applicable results. The critical analysis of every source would assist the healthcare providers in making an evidence-based decision that would lead to the best outcomes for the AMI patients.

Conclusion

The application of the evidence-based practice model plays a vital role in the treatment decision-making in the management of AMI. JHNEBP Model assists in offering a systematic approach in assessing treatment choices between medication therapy and surgical procedures, and applying evidence-based plausible studies in reaching decisions that would serve the patient. The challenges of studying differences in results can be overcome through good integration of evidence and clinical expertise to offer safe and effective care. In turn, the strategy is the embodiment of the importance of evidence-based practice in terms of the refinements of the treatment strategy and creation of patient-centered care, which will be relevant to the delivery of individualized care and enhancement of the long-term recovery of AMI patients.